Arkolith/Insider Trading/OCEL/Form 4

Leider Harry L.

Chief Executive Officer, DirectorOrganicell Regenerative Medicine, Inc. (OCEL) · full profile →Form 4 · filed Dec 20, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 19, 2023Sell(S)5K$1.32$7K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001829126-23-008139) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML